Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NORRIS MEDICINES vs CONCORD BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NORRIS MEDICINES CONCORD BIOTECH NORRIS MEDICINES/
CONCORD BIOTECH
 
P/E (TTM) x -21.8 64.4 - View Chart
P/BV x - 13.9 - View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 NORRIS MEDICINES   CONCORD BIOTECH
EQUITY SHARE DATA
    NORRIS MEDICINES
Mar-24
CONCORD BIOTECH
Mar-24
NORRIS MEDICINES/
CONCORD BIOTECH
5-Yr Chart
Click to enlarge
High Rs281,608 1.7%   
Low Rs10900 1.1%   
Sales per share (Unadj.) Rs5.697.2 5.8%  
Earnings per share (Unadj.) Rs-1.229.4 -4.0%  
Cash flow per share (Unadj.) Rs-0.634.6 -1.8%  
Dividends per share (Unadj.) Rs08.75 0.0%  
Avg Dividend yield %00.7 0.0%  
Book value per share (Unadj.) Rs-13.6145.9 -9.3%  
Shares outstanding (eoy) m10.00104.62 9.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.312.9 25.8%   
Avg P/E ratio x-15.842.6 -37.2%  
P/CF ratio (eoy) x-30.536.3 -84.2%  
Price / Book Value ratio x-1.48.6 -16.0%  
Dividend payout %029.7 -0.0%   
Avg Mkt Cap Rs m188131,199 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m181,230 1.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5610,169 0.6%  
Other income Rs m0338 0.1%   
Total revenues Rs m5710,507 0.5%   
Gross profit Rs m-24,356 -0.0%  
Depreciation Rs m6536 1.1%   
Interest Rs m432 11.6%   
Profit before tax Rs m-114,126 -0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m11,045 0.1%   
Profit after tax Rs m-123,081 -0.4%  
Gross profit margin %-3.342.8 -7.7%  
Effective tax rate %-8.125.3 -32.0%   
Net profit margin %-21.130.3 -69.5%  
BALANCE SHEET DATA
Current assets Rs m618,962 0.7%   
Current liabilities Rs m921,422 6.5%   
Net working cap to sales %-54.774.2 -73.8%  
Current ratio x0.76.3 10.6%  
Inventory Days Days8494 89.4%  
Debtors Days Days68,690,4741,255 5,474,142.2%  
Net fixed assets Rs m718,045 0.9%   
Share capital Rs m99105 94.9%   
"Free" reserves Rs m-23615,162 -1.6%   
Net worth Rs m-13615,266 -0.9%   
Long term debt Rs m1860-   
Total assets Rs m13217,007 0.8%  
Interest coverage x-2.0130.6 -1.5%   
Debt to equity ratio x-1.40-  
Sales to assets ratio x0.40.6 71.3%   
Return on assets %-6.218.3 -33.8%  
Return on equity %8.720.2 43.1%  
Return on capital %-14.727.2 -53.9%  
Exports to sales %7.645.9 16.5%   
Imports to sales %012.6 0.0%   
Exports (fob) Rs m44,670 0.1%   
Imports (cif) Rs mNA1,279 0.0%   
Fx inflow Rs m44,670 0.1%   
Fx outflow Rs m01,279 0.0%   
Net fx Rs m43,390 0.1%   
CASH FLOW
From Operations Rs m22,655 0.1%  
From Investments Rs m1-1,546 -0.0%  
From Financial Activity Rs m-2-992 0.2%  
Net Cashflow Rs m0116 0.1%  

Share Holding

Indian Promoters % 58.6 44.1 133.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.1 17.9 0.7%  
FIIs % 0.0 8.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 41.4 55.9 74.0%  
Shareholders   25,497 84,298 30.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NORRIS MEDICINES With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on NORRIS MEDI. vs CONCORD BIOTECH

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NORRIS MEDI. vs CONCORD BIOTECH Share Price Performance

Period NORRIS MEDI. CONCORD BIOTECH S&P BSE HEALTHCARE
1-Day -4.97% 1.78% 1.28%
1-Month 13.67% 9.95% -0.19%
1-Year 65.94% 60.29% 43.70%
3-Year CAGR 23.02% 29.05% 20.37%
5-Year CAGR 42.93% 16.53% 26.26%

* Compound Annual Growth Rate

Here are more details on the NORRIS MEDI. share price and the CONCORD BIOTECH share price.

Moving on to shareholding structures...

The promoters of NORRIS MEDI. hold a 58.6% stake in the company. In case of CONCORD BIOTECH the stake stands at 44.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NORRIS MEDI. and the shareholding pattern of CONCORD BIOTECH.

Finally, a word on dividends...

In the most recent financial year, NORRIS MEDI. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

CONCORD BIOTECH paid Rs 8.8, and its dividend payout ratio stood at 29.7%.

You may visit here to review the dividend history of NORRIS MEDI., and the dividend history of CONCORD BIOTECH.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.